A 4-Year-Old Boy with Beckwith Wiedemann Syndrome (BWS)


Objectives: Molecular characterization of a patient with BWS.

Clinical presentation and intervention: A 4-year-old boy with overgrowth (weight above 99th and height at 99th percentile) had longitudinal hemihypertrophy of the tongue and left cheek. In addition, there was a difference of one centimeter in the circumference of the left and right leg. Molecular genetic analysis revealed hypomethylation of KvDRM1 (LIT1) in the imprinting control region-2 (ICR2) on chromosome 11p15.5 and a normal methylation pattern of the H19-differentially methylated region (H19-DMR) in the ICR1. The estimated tumor risk was 1-5%.

Conclusion: This patient with clinical characteristics of BWS has an imprinting defect associated with a low risk of embryonal tumors.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Weksberg, R, Shuman C, Beckwith JB. Beck-with-Wiedemann syndrome. Europ J Hum Genet. 2010; 18: 8–14.

  • 2. Firth HV, Hurst JA, Hall JG. Beckwith-Wiedemann syndrome (BWS). In: Oxford desk reference: Clinical genetics. Oxford desk reference, 278–279. Oxford University Pres, 2005.

  • 3. Mussa A, Russo S, Larizza L, Riccio A, Ferrero GB. (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome: a paradigm for genomic medicine. Clin Genet 2016; 89: 403–415.

  • 4. Shuman C, Beckwith JB, Smith AC, et al. Beck-with-Wiedemann Syndrome. 2000 [Updated 2010 Dec 14]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2015.

  • 5. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002.

  • 6. Baskin B, Choufani S, Chen YA, Shuman C, Parkinson N, Lemyre E, Micheil Innes A, Stavropoulos DJ, Ray PN, Weksberg R. High frequency of copy number variations (CNVs) in the chromosome 11p15 region in patients with Beck-with-Wiedemann syndrome. Hum Genet. 2014; 133(3): 321–30.

  • 7. Rump P, Zeegers MP, van Essen AJ. Tumor risk in Beckwith-Wiedemann syndrome: A review and meta-analysis. Am J Med Genet A. 2005; 136(1): 95–104.

  • 8. DeBaun MR, Niemitz EL, McNiel DE, Branderbirg SA, Lee MP, Feinberg AP. Epigenetic Alterations of H19 and LIT1 Distinguish Patients with Beckwith-Wiedemann Syndrome with Cancer and Birth Defects. Am J Hum Genet. 2002; 70: 604–611.

  • 9. Martinez-y-Martinez R, Martinez-Carboney R, Ocampo-Campos R, Rivera H, Gomez Plascencia y Castillo J, Cuevas A, Martin Manrique MC. Wiedemann-Beckwith syndrome: clinical, cytogenetical and radiological observations in 39 new cases. Genet Counsel. 1992; 3: 67–76.

  • 10. Clericuzio CL, Martin RA. Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia. Genet Med. 2009; 11: 220–222.


Journal + Issues